Literature DB >> 1378105

Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection.

V E Gould1, V Martinez-Lacabe, I Virtanen, K M Sahlin, M M Schwartz.   

Abstract

BACKGROUND: Acute and chronic renal allograft rejection injuries involve, albeit variably, all compartments of the organ and are associated with significant structural changes. We hoped to gain new insights into these phenomena by determining distribution of certain extracellular matrix proteins known to be involved in architectural remodeling processes. EXPERIMENTAL
DESIGN: Frozen tissue samples from biopsies of acute (n = 14) and chronic (n = 12) human renal allograft rejections were studied to compare distribution of tenascin, the extradomains A and B (EDA, EDB), and oncofetal (Onc) isoforms of cellular fibronectin (cFn). Normal kidneys (n = 4) served as controls. Cryosections were immunostained by the avidin-biotin-complex method with monoclonal antibodies specific for those molecules.
RESULTS: In acute rejection, reactivity for tenascin and EDA-cFn was increased slightly to moderately in glomerular mesangia and in most vessels while it was intensely and diffusely increased in the interstitium. Rarely were focal EDB-cFn and Onc-cFn reactions seen in lesions deemed to reflect acute injury. In chronic rejection, tenascin and EDA-cFn were strongly increased in most glomerular mesangia and in vascular walls but unevenly in the interstitium. In rare glomerular synechiae and vessels, enhanced staining for tenascin and EDA-cFn as well as EDB-cFn and Onc-cFn was noted while in obsolete glomeruli only EDB-cFn and Onc-cFn were detected. The enhanced distribution of tenascin and EDA-cFn partly reflected that noted during nephrogenesis, whereas staining patterns for EDB-cFn and Onc-cFn differed from their fetal counterparts.
CONCLUSIONS: Tenascin and EDA-cFn are strongly and preferentially expressed in the interstitial and vascular compartments of acute and chronic renal rejection injury suggesting that, in these sites, active repair and remodeling occur during both phases of the rejection process irrespective of the changes seen by conventional microscopy. Tenascin, EDA-cFn as well as EDB-cFn and Onc-cFn are all involved, albeit variably, in the glomerular and vascular alterations of chronic rejection. The finding of tenascin and of the three isoforms of cFn in glomerular synechiae with actively proliferating epithelium suggests that certain epithelial cells might partake in the synthesis of these molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378105

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  16 in total

1.  Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.

Authors:  J George; S S Wang; A M Sevcsik; M Sanicola; R L Cate; V E Koteliansky; D M Bissell
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

2.  A novel, nuclear pore-associated, widely distributed molecule overexpressed in oncogenesis and development.

Authors:  V E Gould; N Martinez; A Orucevic; J Schneider; A Alonso
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

3.  Regulation of fibronectin splicing in sinusoidal endothelial cells from normal or injured liver.

Authors:  Ming-Ling Chang; Jeng-Chang Chen; Claudio R Alonso; Alberto R Kornblihtt; D Montgomery Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-16       Impact factor: 11.205

4.  Expression of tenascin-C in aseptic loosening of total hip replacement.

Authors:  Y T Konttinen; T F Li; O Michelsson; J W Xu; T Sorsa; S Santavirta; S Imai; I Virtanen
Journal:  Ann Rheum Dis       Date:  1998-10       Impact factor: 19.103

Review 5.  VLA-4 and lymphocyte trafficking in immune-inflammatory states: novel therapeutic approaches in allograft arteriopathy.

Authors:  S Molossi; M Rabinovitch
Journal:  Springer Semin Immunopathol       Date:  1995

6.  Enhanced tenascin expression in cervical and vulvar koilocytotic lesions.

Authors:  O Tiitta; T Wahlström; J Paavonen; A Linnala; S Sharma; V E Gould; I Virtanen
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

7.  Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis.

Authors:  J L Barnes; R R Hastings; M A De la Garza
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

8.  Fibrous wound repair associated with biodegradable poly-L/D-lactide copolymer implants: study of the expression of tenascin and cellular fibronectin.

Authors:  R Kontio; A Salo; R Suuronen; C Lindqvist; J H Meurman; I Virtanen
Journal:  J Mater Sci Mater Med       Date:  1998-10       Impact factor: 3.896

9.  Biocompatibility of solid poly (ortho ester).

Authors:  M Ekholm; A Salo; S Syrjänen; P Laine; C Lindqvist; M Kellomäki; I Virtanen; R Suuronen
Journal:  J Mater Sci Mater Med       Date:  1997-05       Impact factor: 3.896

10.  Mixture of epsilon-caprolactone-lactide copolymer and tricalcium phosphate: a histological and immunohistochemical study of tissue reactions.

Authors:  M Ekholm; J Hietanen; C Lindqvist; J Rautavuori; S Santavirta; A Salo; J Seppälä; R Suuronen
Journal:  J Mater Sci Mater Med       Date:  1999-02       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.